THE BISPHOSPHONATE ZOLEDRONIC ACID DECREASES TUMOR GROWTH IN BONE IN MICE WITH DEFECTIVE OSTEOCLASTS

Bisphosphonates (BPs), bone targeted drugs that disrupt osteoclast function, are routinely used to treat complications of bone metastasis. Studies in preclinical models of cancer have shown that BPs reduce skeletal tumor burden and increase survival. Similarly, we observed in the present study that...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Hirbe, Angela C., Roelofs, Anke J., Floyd, Desiree H., Deng, Hongju, Becker, Stephanie N., Lanigan, Lisa G., Apicelli, Anthony J., Xu, Zhiqiang, Prior, Julie L., Eagleton, Mark C., Piwnica-Worms, David, Rogers, Michael J., Weilbaecher, Katherine
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2009
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC2782613/
https://ncbi.nlm.nih.gov/pubmed/19442620
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bone.2009.01.010
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak